PRESS RELEASE | Basel, Switzerland, October 4, 2021
Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, today announces its participation in the 21st Annual Biotech in Europe Forum organized by SACHS Associates taking place virtually 7th-8th October 2021.